Changes in urinary metabolic profile after oral administration of curcuma extract in rats

Journal of Pharmaceutical and Biomedical Analysis

Volumn 100, Issue , 2014, Pages 348-356

  Dall'Acqua, Stefano ^a   Stocchero, Matteo ^b   Clauser, Maria ^a   Boschiero, Irene ^a   Ndoum, Emmanuel ^a   Schiavon, Mariano ^a   Mammi, Stefano ^a   Schievano, Elisabetta ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b S IN Soluzioni Informatiche   (Italy)

Author keywords

ASCA; Curcumin; HPLC MS; Metabolomic; NMR

Indexed keywords

2,4 DIHYDROXYQUINOLINE; 8 HYDROXY 3,4 DIHYDROQUINOLIN 2(1H) ONE; ALLANTOIN; CITRIC ACID; CREATININE; CURCUMA LONGA EXTRACT; CURCUMIN; DICARBOXYLIC ACID; HIPPURIC ACID; QUINOLINE DERIVATIVE; QUINOLONE DERIVATIVE; TAURINE; UNCLASSIFIED DRUG; ANTIOXIDANT; BIOLOGICAL MARKER; PLANT EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLOMICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; URINALYSIS; URINE LEVEL; ANIMAL; BIOTRANSFORMATION; CURCUMA; DRUG EFFECTS; MEDICINAL PLANT; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PHYTOTHERAPY; PROCEDURES; SPRAGUE DAWLEY RAT; URINE;

ADMINISTRATION, ORAL; ALLANTOIN; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMA; CURCUMIN; FEMALE; MALE; MASS SPECTROMETRY; METABOLOMICS; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RATS, SPRAGUE-DAWLEY;

EID: 84908568077     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.07.035     Document Type: Article

References (55)

1. Kelsey N.A., Wilkins H.M., Linseman D.A. Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010, 15:7792-7814. 10.3390/molecules15117792.
2. Zuchi C., Ambrosio G., Lüscher T.F., Landmesser U. Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function. Cardiovasc. Ther. 2010, 28:187-201. 10.1111/j.1755-5922.2010.00165.x.
3. Fraga C.G., Galleano M., Verstraeten S.V., Oteiza P.I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol. Asp. Med. 2010, 31:435-445. 10.1016/j.mam.2010.09.006.
4. Espín J.C., García-Conesa M.T., Tomás-Barberán F.A. Nutraceuticals: facts and fiction. Phytochemistry 2007, 68:2986-3008. 10.1016/j.phytochem.2007.09.014.
5. Ndhlala A.R., Moyo M., Van Staden J. Natural antioxidants: fascinating or mythical biomolecules?. Molecules 2010, 15:6905-6930. 10.3390/molecules15106905.
6. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?. Arch. Biochem. Biophys. 2008, 476:107-112. 10.1016/j.abb.2008.01.028.
7. Manach C., Hubert J., Llorach R., Scalbert A. The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol. Nutr. Food Res. 2009, 53:1303-1315. 10.1002/mnfr.200800516.
8. Efferth T., Koch E. Complex interactions between phytochemicals: the multi-target therapeutic concept of phytotherapy. Curr. Drug Targets 2011, 12:122-132.
9. An D., Zhang Q., Wu S., Wei J., Yang J., Dong F., Yan X., Guo C. Changes of metabolic profiles in urine after oral administration of quercetin in rats. Food Chem. Toxicol. 2010, 48:1521-1527. 10.1016/j.fct.2010.03.019.
10. Llorach R., Garrido I., Monagas M., Urpi-Sarda M., Tulipani S., Bartolome B., Andres-Lacueva C. Metabolomics study of human urinary metabolome modifications after intake of almond (Prunus dulcis (Mill.) D.A. Webb) skin polyphenols. J. Proteome Res. 2010, 9:5859-5867.
11. Llorach-Asunción R., Jauregui O., Urpi-Sarda M., Andres-Lacueva C. Methodological aspects for metabolome visualization and characterization: a metabolomic evaluation of the 24h evolution of human urine after cocoa powder consumption. J. Pharm. Biomed. Anal. 2010, 51:373-381.
12. Llorach R., Urpi-Sarda M., Tulipani S., Garcia-Aloy M., Monagas M., Andres-Lacueva C. Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol. Nutr. Food Res. 2013, 57:962-973.
13. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009, 41:40-59.
14. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem. Pharmacol. 2008, 75:787-809.
15. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 2006, 78:2081-2087.
16. De R., Kundu P., Swarnakar S., Ramamurthy T., Chowdhury A., Nair G.B., Mukhopadhyay A.K. Antimicrobial activity of curcumin against helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 2009, 53:1592-1597.
17. Yadav V.S., Mishra K.P., Singh D.P., Mehrotra S., Singh V.K. Immunomodulatory effects of curcumin. Immunopharmacol. Immunotoxicol. 2005, 27:485-497.
18. Jagetia G.C., Aggarwal B.B. "Spicing up" of the immune system by curcumin. J. Clin. Immunol. 2007, 27:19-35.
19. Varalakshmi C., Ali A.M., Pardhasaradhi B.V.V., Srivastava R.M., Singh S., Khar A. Immunomodulatory effects of curcumin: in-vivo. Int. Immunopharmacol. 2008, 8:688-700.
20. El-Moselhy M.A., Taye A., Sharkawi S.S., El-Sisi S.F.I., Ahmed A.F. The antihyperglycemic effect of curcumin in high fat diet fed rats: role of TNF-α and free fatty acids. Food Chem. Toxicol. 2011, 49:1129-1140.
21. Gupta S.K., Kumar B., Nag T.C., Agrawal S.S., Agrawal R., Agrawal P., Saxena R., Srivastava S. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J. Ocular Pharmacol. Ther. 2011, 27:123-130.
22. Na L.-X., Zhang Y.-L., Li Y., Liu L.-Y., Li R., Kong T., Sun C.-H. Curcumin improves insulin resistance in skeletal muscle of rats. Nutr. Metab. Cardiovasc. Dis. 2011, 21:526-533.
23. Meng B., Li J., Cao H. Antioxidant and anti-inflammatory activities of curcumin on diabetes mellitus and its complications. Curr. Pharm. Des. 2013, 19:2101-2113.
24. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003, 23:363-398.
25. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008, 267:133-164.
26. Hatcher H., Planalp R., Cho J., Torti F.M., Torti S.V. Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. 2008, 65:1631-1652.
27. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005, 280:5892-5901.
28. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
29. Marczylo T.H., Steward W.P., Gescher A.J. Rapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography (UPLC) method. J. Agric. Food Chem. 2009, 57:797-803.
30. Pfeiffer E., Hoehle S.I., Walch S.G., Riess A., Sólyom A.M., Metzler M. Curcuminoids form reactive glucuronides in vitro. J. Agric. Food Chem. 2007, 55:538-544.
31. Veselkov K.A., Vingara L.K., Masson P., Robinette S.L., Want E., Li J.V., Barton R.H., Boursier-Neyret C., Walther B., Ebbels T.M., Pelczer I., Holmes E., Lindon J.C., Nicholson J.K. Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Anal. Chem. 2011, 83:5864-5872.
32. Jackson J.E. A Users Guide to Principal Components 1991, John Wiley, New York.
33. Smilde A.K., Jansen J.J., Hoefsloot H.C.J., Lamers R.-A.N., van der Greef J., Timmerman M.E. ANOVA-simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data. Bioinformatics 2005, 21:3043-3048.
34. Vis D.J., Westerhuis J.A., Smilde A.K., van der Greef J. Statistical validation of megavariate effects in ASCA. BMC Bioinformatics 2007, 8:322.
35. Ergon R. PLS post-processing by similarity transformation (PLS+ST): a simple alternative to OPLS. J. Chemometr. 2005, 19:1-4.
36. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
37. Payton F., Sandusky P., Alworth W.L. NMR study of the solution structure of curcumin. J. Nat. Prod. 2007, 70:143-146.
38. Shen L., Ji H. Theoretical study on physicochemical properties of curcumin. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2007, 67:619-623.
39. 1H NMR and HPLC-TOF MS. Mol. Biosyst. 2005, 1:166-175.
40. Nicholson J.K., Wilson I.D. Understanding "global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2003, 2:668-676.
41. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., Marczylo T.H., Morgan B., Hemingway D., Plummer S.M., Pirmohamed M., Gescher A.J., Steward W.P. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 2004, 10:6847-6854.
42. Pan M.-H., Huang T.-M., Lin J.-K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 1999, 27:486-494.
43. Ireson C., Orr S., Jones D.J.L., Verschoyle R., Lim C.-K., Luo J.-L., Howells L., Plummer S., Jukes R., Williams M., Steward W.P., Gescher A. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001, 61:1058-1064.
44. Ireson C.R., Jones D.J.L., Orr S., Coughtrie M.W.H., Boocock D.J., Williams M.L., Farmer P.B., Steward W.P., Gescher A.J. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 2002, 11:105-111.
45. Phipps A.N., Stewart J., Wright B., Wilson I.D. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat: a complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 1998, 28:527-537.
46. Mortishire-Smith R.J., Skiles G.L., Lawrence J.W., Spence S., Nicholls A.W., Johnson B.A., Nicholson J.K. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem. Res. Toxicol. 2004, 17:165-173.
47. Krupp D., Doberstein N., Shi L., Remer T. Hippuric acid in 24-h urine collections is a potential biomarker for fruit and vegetable consumption in healthy children and adolescents. J. Nutr. 2012, 142:1314-1320.
48. Rechner A.R., Kuhnle G., Bremner P., Hubbard G.P., Moore K.P., Rice-Evans C.A. The metabolic fate of dietary polyphenols in humans. Free Radic. Biol. Med. 2002, 33:220-235. 10.1016/S0891-5849(02)00877-8.
49. Gregersen N., Mortensen P.B., Kolvraa S. On the biologic origin of C6-C10-dicarboxylic and C6-C10-ω-1-hydroxy monocarboxylic acids in human and rat with acyl-CoA dehydrogenation deficiencies: in vitro studies on the ω- and ω-1-oxidation of medium-chain (C6-C12) fatty acids in human and rat liver. Pediatr Res. 1983, 17:828-834.
50. Yang J., Sun X., Feng Z., Hao D., Wang M., Zhao X., Sun C. Metabolomic analysis of the toxic effects of chronic exposure to low-level dichlorvos on rats using ultra-performance liquid chromatography-mass spectrometry. Toxicol. Lett. 2011, 206:306-313.
51. Wang H., Li S., Qi L., Xu W., Zeng Y., Hou Y., Zhao X., Sun C. Metabonomic analysis of quercetin against the toxicity of chronic exposure to low-level dichlorvos in rats via ultra-performance liquid chromatography-mass spectrometry. Toxicol. Lett. 2014, 225:230-239.
52. Dawson R., Liu S., Eppler B., Patterson T. Effects of dietary taurine supplementation or deprivation in aged male Fischer 344 rats. Mech. Ageing Dev. 1999, 107:73-91. 10.1016/S0047-6374(98)00138-9.
53. Pyrzanowska J., Piechal A., Blecharz-Klin K., Lehner M., Skórzewska A., Turzynska D., Sobolewska A., Plaznik A., Widy-Tyszkiewicz E. The influence of the long-term administration of Curcuma longa extract on learning and spatial memory as well as the concentration of brain neurotransmitters and level of plasma corticosterone in aged rats. Pharmacol. Biochem. Behav. 2010, 95:351-358.
54. Clayton T.A., Lindon J.C., Everett J.R., Charuel C., Hanton G., Le Net J.-L., Provost J.-P., Nicholson J.K. An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria. Arch. Toxicol. 2003, 77:208-217.
55. Il'yasova D., Scarbrough P., Spasojevic I. Urinary biomarkers of oxidative status. Clin. Chim. Acta 2012, 413:1446-1453.